Clinical Trial Update: BRAF V600E Mutations In Papillary Thyroid Carcinoma [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 clinical trial from Bezmialem Vakif University is evaluating BRAF V600E mutations in papillary thyroid carcinoma. The current status of the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Papillary Thyroid Carcinoma

Snippet

Sponsor: Bezmialem Vakif University | Conditions: Papillary Thyroid Carcinoma | EARLY_Phase 1 | Status: UNKNOWN